Aditxt Stock (NASDAQ:ADTX), Quotes and News Summary

Q: What sector and industry does Aditxt (ADTX) operate in?

Aditxt is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Aditxt Stock (NASDAQ: ADTX) stock price, news, charts, stock research, profile.

Open	$2.025
Close	$2.090
Volume / Avg.	19.379K / 350.495K
Day Range	2.013 - 2.120
52 Wk Range	1.945 - 68.080
Market Cap	$3.347M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	10.02%
Days to Cover	3.25

Recent News

Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

Avi Kapoor

Why Aditxt Stock Is Volatile Today

Aditxt's wholly owned subsidiary, Adivir, Inc. will acquire all issued and outstanding Class A common shares of Appili in the transaction. Appili has developed FDA-approved Likmez (previously ATI-1501), its ATI-1701 biodefense program supported by a USD $14 million non-dilutive award from the U.S Department of Defense, and its ATI-1801 topical formulation targeting cutaneous leishmaniasis.

Erica Kollmann

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Longboard Pharmaceuticals, Inc.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aditxt (ADTX) stock?

You can purchase shares of Aditxt (NASDAQ: ADTX) through any online brokerage.

View our list of the best stock brokerages.

Who are Aditxt's (ADTX) competitors?

Other companies in Aditxt’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).

What is the target price for Aditxt (ADTX) stock?

The latest price target for Aditxt (NASDAQ: ADTX) was reported by HC Wainwright & Co. on Wednesday, September 6, 2023. The analyst firm set a price target for 61.00 expecting ADTX to rise to within 12 months (a possible 2934.83% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Aditxt (ADTX)?

The stock price for Aditxt (NASDAQ: ADTX) is $2.01 last updated May 20, 2024 at 8:26 AM EDT.

Does Aditxt (ADTX) pay a dividend?

There are no upcoming dividends for Aditxt.

When is Aditxt (NASDAQ:ADTX) reporting earnings?

Aditxt’s Q2 earnings are confirmed for Monday, August 12, 2024.

Is Aditxt (ADTX) going to split?

There is no upcoming split for Aditxt.

What sector and industry does Aditxt (ADTX) operate in?

Aditxt is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-